FDA Approved: NEXVIAZYME — Original Application (Genzyme Corporation)

View source ↗

Summary

FDA approved Nexviazyme (avalglucosidase alfa-ngpt) from Genzyme Corporation under the original BLA. It is indicated for Pompe disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Drugs mentioned

• NEXVIAZYME (avalglucosidase alfa)

Snippet

ORIG AP for NEXVIAZYME (AVALGLUCOSIDASE ALFA-NGPT)